688488 艾迪藥業
按盤價 
9.350 -0.160 (-1.682%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -5.553 | -6.545 | -9.893 | -2.246 | 4.151 |
| 總資產報酬率 ROA (%) | -3.317 | -4.472 | -8.032 | -2.081 | 3.570 |
| 投入資產回報率 ROIC (%) | -3.881 | -5.052 | -8.871 | -2.198 | 3.815 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.811 | 46.195 | 42.901 | 33.191 | 50.092 |
| 營業利潤率 (%) | -25.874 | -22.376 | -58.175 | -17.143 | 17.142 |
| 息稅前利潤/營業總收入 (%) | -23.072 | -19.843 | -58.139 | -17.375 | 16.860 |
| 淨利潤/營業總收入 (%) | -20.652 | -18.492 | -50.812 | -11.726 | 13.759 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.755 | 96.928 | 91.603 | 123.454 | 66.793 |
| 價值變動淨收益/利潤總額(%) | -39.378 | -15.376 | -11.805 | -19.142 | 6.451 |
| 營業外收支淨額/利潤總額(%) | 1.487 | 0.040 | 0.218 | -3.697 | -5.013 | 償債能力分析 |
| 流動比率 (X) | 1.507 | 1.775 | 2.419 | 8.936 | 13.790 |
| 速動比率 (X) | 1.113 | 1.399 | 1.949 | 7.701 | 12.584 |
| 資產負債率 (%) | 40.226 | 35.557 | 27.578 | 8.700 | 6.011 |
| 帶息債務/全部投入資本 (%) | 28.616 | 23.719 | 13.326 | -0.187 | 1.119 |
| 股東權益/帶息債務 (%) | 235.491 | 305.446 | 617.002 | -52,227.997 | 8,743.116 |
| 股東權益/負債合計 (%) | 137.854 | 181.238 | 262.608 | 1,049.375 | 1,563.592 |
| 利息保障倍數 (X) | -7.225 | -7.805 | -356.435 | 20.612 | 31.411 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 149.500 | 129.628 | 126.837 | 126.673 | 170.121 |
| 存貨周轉天數 (天) | 411.123 | 277.339 | 349.064 | 213.182 | 191.791 |
| 備註： | 即時報價更新時間為 04/12/2024 13:48 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
